Importantly, reduced TRAIL levels may inhibit TRAIL-induced apoptosis and promote the persistence of virus-infected cells, thereby enhancing inflammatory responses, which provides a novel potential target for early prediction and intervention of respiratory failure correction or severe disease progression control in elderly patients with COVID-19. The gene discussed is TNFSF10; the disease is COVID-19.